0001209191-20-060894.txt : 20201201
0001209191-20-060894.hdr.sgml : 20201201
20201201163149
ACCESSION NUMBER: 0001209191-20-060894
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201127
FILED AS OF DATE: 20201201
DATE AS OF CHANGE: 20201201
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Goone David S
CENTRAL INDEX KEY: 0001343869
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36198
FILM NUMBER: 201361213
MAIL ADDRESS:
STREET 1: 2100 RIVEREDGE PARKWAY
STREET 2: SUITE 500
CITY: ATLANTA
STATE: GA
ZIP: 30308
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Intercontinental Exchange, Inc.
CENTRAL INDEX KEY: 0001571949
STANDARD INDUSTRIAL CLASSIFICATION: SECURITY & COMMODITY BROKERS, DEALERS, EXCHANGES & SERVICES [6200]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5660 NEW NORTHSIDE DRIVE,
STREET 2: THIRD FLOOR
CITY: ATLANTA
STATE: GA
ZIP: 30328
BUSINESS PHONE: 770-857-4700
MAIL ADDRESS:
STREET 1: 5660 NEW NORTHSIDE DRIVE,
STREET 2: THIRD FLOOR
CITY: ATLANTA
STATE: GA
ZIP: 30328
FORMER COMPANY:
FORMER CONFORMED NAME: IntercontinentalExchange Group, Inc.
DATE OF NAME CHANGE: 20130313
FORMER COMPANY:
FORMER CONFORMED NAME: Intercontinental Exchange Group, Inc.
DATE OF NAME CHANGE: 20130312
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-11-27
0
0001571949
Intercontinental Exchange, Inc.
ICE
0001343869
Goone David S
5660 NEW NORTHSIDE DRIVE
ATLANTA
GA
30328
0
1
0
0
Chief Strategic Officer
Common Stock
2020-11-27
4
M
0
5514
41.37
A
186243
D
Common Stock
2020-11-27
4
S
0
5514
105.0044
D
180729
D
Common Stock
2020-11-30
4
M
0
17281
41.37
A
198010
D
Common Stock
2020-11-30
4
S
0
17281
105.0463
D
180729
D
Employee Stock Option (right to buy) Holding
41.37
2020-11-27
4
M
0
5514
0.00
D
2024-01-17
Common Stock
5514
40076
D
Employee Stock Option (right to buy) Holding
41.37
2020-11-30
4
M
0
17281
0.00
D
2024-01-17
Common Stock
17281
22795
D
The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.
The price range for the aggregate amount sold by the direct holder is $105.00 - $105.03. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
The price range for the aggregate amount sold by the direct holder is $105.00 - $105.15. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
The common stock number referred in Table I is an aggregate number and represents 160,197 shares of common stock and 20,532 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2020 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021 and will be reported at the time of vesting. The satisfaction of the 2018, 2019 and 2020 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021, February 2022 and February 2023, respectively, and will be reported at the time of vesting.
These options are fully vested.
/s/ Octavia N. Spencer, Attorney-in-fact
2020-12-01